Fundraising FoxBexionpharma
1 known investors
Find your way into Bexionpharma
Sign up to see every warm intro you have to Bexionpharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Bexionpharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bexion Pharmaceuticals is a clinical-stage biopharmaceutical company developing biologic cancer therapies that target dysregulated sphingolipid metabolism to counter tumor survival and treatment resistance. Its lead program, BXQ-350, is being studied in patients with advanced solid tumors, including metastatic colorectal cancer.
Founders & leadership
Investors · 1
Related companies · 2
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Lexicon PharmaceuticalsLexicon Pharmaceuticals develops and commercializes pharmaceutical products, including the marketed drug INPEFA and drug candidates in clinical development such as sotagliflozin, pilavapadin, and LX9851, serving patients in need of treatments across various therapeutic areas.
Companies working in the same space as Bexionpharma.
In the news
Frequently asked questions
- What does Bexionpharma do?
- Bexion Pharmaceuticals is a clinical-stage biopharmaceutical company developing biologic cancer therapies that target dysregulated sphingolipid metabolism to counter tumor survival and treatment resistance. Its lead program, BXQ-350, is being studied in patients with advanced solid tumors, including metastatic colorectal cancer.
- Who founded Bexionpharma?
- Bexionpharma was founded by Scott Shively.
- Who are Bexionpharma's investors?
- Bexionpharma's investors include Keyhorse Capital.